HUP0402334A2 - Módosított humán növekedési hormon - Google Patents
Módosított humán növekedési hormonInfo
- Publication number
- HUP0402334A2 HUP0402334A2 HU0402334A HUP0402334A HUP0402334A2 HU P0402334 A2 HUP0402334 A2 HU P0402334A2 HU 0402334 A HU0402334 A HU 0402334A HU P0402334 A HUP0402334 A HU P0402334A HU P0402334 A2 HUP0402334 A2 HU P0402334A2
- Authority
- HU
- Hungary
- Prior art keywords
- modified
- hgh
- polypeptides
- growth hormone
- human growth
- Prior art date
Links
- 102000002265 Human Growth Hormone Human genes 0.000 title abstract 7
- 108010000521 Human Growth Hormone Proteins 0.000 title abstract 7
- 239000000854 Human Growth Hormone Substances 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 230000002163 immunogen Effects 0.000 abstract 2
- 230000008105 immune reaction Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A találmány tárgyát olyan polipeptidek képezik, amelyek - elsősorbanterápiás célból - speciálisan embereknek adagolhatók. A találmányszerinti polipeptidek módosított polipeptidek, mely módosításeredményeként a polipeptid - embereknek történő adagolása esetén -kevésbé hajlamos immunreakció kiváltására. Közelebbről, a találmánytárgyát humán növekedési hormon (hGH) módosított változatai képezik,mely hGH-proteinváltozatok in vivo alkalmazáskor lényegében nemimmunogének vagy kevésbé immunogének, mint a megfelelő, módosításnélküli alakjuk. A találmány tárgyát képezik továbbá a találmányszerinti módosított hGH-molekulákat kódoló DNS-ek, a találmányszerinti módosított hGH-molekulákat tartalmazó gyógyászatikészítmények, valamint eljárások a módosított hGH-molekulákelőállítására. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01121153 | 2001-09-04 | ||
| PCT/EP2002/009716 WO2003020761A1 (en) | 2001-09-04 | 2002-08-30 | Modified human growth hormone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0402334A2 true HUP0402334A2 (hu) | 2005-02-28 |
| HUP0402334A3 HUP0402334A3 (en) | 2007-03-28 |
Family
ID=8178533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0402334A HUP0402334A3 (en) | 2001-09-04 | 2002-08-30 | Modified human growth hormone |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050020494A1 (hu) |
| EP (1) | EP1427756A1 (hu) |
| JP (1) | JP2005501546A (hu) |
| KR (1) | KR20040039323A (hu) |
| CN (1) | CN1551888A (hu) |
| BR (1) | BR0211991A (hu) |
| CA (1) | CA2459138A1 (hu) |
| HU (1) | HUP0402334A3 (hu) |
| MX (1) | MXPA04001976A (hu) |
| PL (1) | PL369066A1 (hu) |
| RU (1) | RU2004110238A (hu) |
| WO (1) | WO2003020761A1 (hu) |
| ZA (1) | ZA200402602B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2498319A1 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| JP4896745B2 (ja) * | 2004-02-02 | 2012-03-14 | アンブレツクス・インコーポレイテツド | 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用 |
| EP1640382A1 (en) * | 2004-08-16 | 2006-03-29 | Université de Liège | Anti-angiogenic peptides |
| US7998930B2 (en) * | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
| US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
| CA2691539C (en) * | 2007-06-21 | 2014-08-26 | Angelica Therapeutics, Inc. | Modified toxins |
| WO2009110944A1 (en) * | 2008-02-29 | 2009-09-11 | Angelica Therapeutics, Inc. | Modified toxins |
| CA2902905A1 (en) | 2013-03-15 | 2014-09-25 | Claude Geoffrey Davis | Modified toxins |
| US11396254B2 (en) | 2017-09-07 | 2022-07-26 | Custom Truck & Equipment LLC | Railcar-mover vehicle |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0561907B1 (en) * | 1990-12-05 | 1998-09-02 | Novo Nordisk A/S | Proteins with changed epitopes and methods for the production thereof |
| US5686268A (en) * | 1992-06-19 | 1997-11-11 | Pfizer Inc. | Fused proteins |
| DE69833755T2 (de) * | 1997-05-21 | 2006-12-28 | Biovation Ltd. | Verfahren zur herstellung von nicht-immunogenen proteinen |
| GB9712892D0 (en) * | 1997-06-20 | 1997-08-20 | Eclagen Ltd | Identification of mhc binding peptides |
| JP2002534959A (ja) * | 1998-12-08 | 2002-10-22 | バイオベーション リミテッド | 免疫原性タンパク質の改変方法 |
-
2002
- 2002-08-30 WO PCT/EP2002/009716 patent/WO2003020761A1/en not_active Application Discontinuation
- 2002-08-30 CA CA002459138A patent/CA2459138A1/en not_active Abandoned
- 2002-08-30 HU HU0402334A patent/HUP0402334A3/hu unknown
- 2002-08-30 PL PL02369066A patent/PL369066A1/xx unknown
- 2002-08-30 BR BR0211991-9A patent/BR0211991A/pt not_active Application Discontinuation
- 2002-08-30 KR KR10-2004-7003170A patent/KR20040039323A/ko not_active Application Discontinuation
- 2002-08-30 RU RU2004110238/04A patent/RU2004110238A/ru not_active Application Discontinuation
- 2002-08-30 US US10/488,662 patent/US20050020494A1/en not_active Abandoned
- 2002-08-30 EP EP02769987A patent/EP1427756A1/en not_active Withdrawn
- 2002-08-30 JP JP2003525031A patent/JP2005501546A/ja not_active Withdrawn
- 2002-08-30 MX MXPA04001976A patent/MXPA04001976A/es not_active Application Discontinuation
- 2002-08-30 CN CNA028172779A patent/CN1551888A/zh active Pending
-
2004
- 2004-04-01 ZA ZA200402602A patent/ZA200402602B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0211991A (pt) | 2004-09-28 |
| RU2004110238A (ru) | 2005-10-20 |
| CN1551888A (zh) | 2004-12-01 |
| JP2005501546A (ja) | 2005-01-20 |
| HUP0402334A3 (en) | 2007-03-28 |
| CA2459138A1 (en) | 2003-03-13 |
| EP1427756A1 (en) | 2004-06-16 |
| KR20040039323A (ko) | 2004-05-10 |
| US20050020494A1 (en) | 2005-01-27 |
| WO2003020761A1 (en) | 2003-03-13 |
| ZA200402602B (en) | 2005-05-06 |
| MXPA04001976A (es) | 2004-06-07 |
| PL369066A1 (en) | 2005-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401534A2 (hu) | Módosított humán IX. faktor | |
| HUP0400700A2 (hu) | Csökkentett immunogenitású, módosított humán agyi eredetű neutróf faktor (BDNF) | |
| HUP0203409A2 (hu) | Gamma-interferon-konjugátumok | |
| HUP0002095A2 (hu) | Vegyületek prosztatarák immunterápiás kezelésére és alkalmazásuk | |
| DE50004018D1 (de) | Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen | |
| PL2087904T3 (pl) | Zastosowanie terapeutyczne peptydów pochodzących z białek BcL-XL u pacjentów z rakiem | |
| DE3856180D1 (de) | Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren | |
| HUP0402071A2 (hu) | Csökkentett immunogenitású, módosított leptin | |
| NL300830I1 (nl) | Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten | |
| HUP0400703A2 (hu) | Csökkentett immunogenitású módosított eritropoietin (EPO) | |
| DK0750672T3 (da) | DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse | |
| HUP0303534A2 (hu) | Csökkent immunogenitású módosított interferon-béta | |
| HUP0402334A2 (hu) | Módosított humán növekedési hormon | |
| HUP0400698A2 (hu) | Csökkentett immunogenitású módosított interleukin-1-receptor-antagonista (IL-1RA) | |
| HUP0303430A2 (hu) | Csökkentett immunogenitású, módosított protamin | |
| HUP0500637A2 (hu) | Neublasztin polimer konjugátumai és alkalmazási eljárásai | |
| HUP0100267A2 (hu) | Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények | |
| NZ508505A (en) | Treatment of wounds using an Egr-1 transcription factor polypeptide | |
| HUP0303309A2 (hu) | Csökkentett immunogenitású módosított interferon-alfa | |
| HUP0401121A2 (hu) | Csökkentett immunogenitású, módosított trombopoietin (TPO) | |
| IL207012A (en) | 28sgp medicinal product and 28sgp accent cancer treatment vaccine | |
| HUP0303310A2 (hu) | Csökkentett immunogenitású módosított ciliáris neurotrofikus faktor (CNTF) | |
| HUP0303150A2 (hu) | Csökkentett immunogenitású, módosított keratinocita növekedési faktor (KGF) | |
| HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására | |
| HUP0402041A2 (hu) | Csökkentett immunogenitású, módosított granulocita-kolonizációt stimuláló faktor (G-CSF) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |